Molecular Diagnostics Market size was valued at USD 24.27 billion in 2023 and is expected to reach at USD 36.94 billion by 2031, and grow at a CAGR of 5.4 % over the forecast period of 2024-2031.
The changing lifestyle and the quality of the food consumption in the developed and the emerging countries because of work stress personal issues and so forth is leading to various disease, the rise in the diabetes and obesity and cardiovascular disease is on high percentage growth, also the rising cancer patients is the concerning factor for the healthcare sector,
Get More Information on Molecular Diagnostics Market - Request Sample Report
The molecular diagnostics also known as molecular pathology is said to the laboratory or clinic where the clinical trial of the human RNA and DNA is done, the basic objective behind the clinical trials is to identify the red flags about the human body in terms of physical health, the test is basically carried out by collecting the samples of the DNA as according to the health experts RNA samples are not stable as DNA is, the most common test done in molecular labs are PCR polymerase chain reaction, According to our qualitative analysis the major objective behind the molecular diagnostics is to identify the disease beforehand so that it can be treated as a soon as possible, and the most common disease which the health professionals have identified is cancer, rigid tumors, infectious disease genetic issue and so forth, the rise in the demand for the molecular diagnostic is mainly because of the rise in the patients, disease and misleading treatment guidance which creates anxiety among the patients in terms of how will they get better treatment and what will the major source because there were cases related to the lack of guidance and support in the undeveloped regions which resulted in negative effect on the patients health, so the molecule diagnostic along with testing also provides treatment and guidance to the patients which is in fact the major factor which will give positive outlook for the molecular diagnostic market another factor which can be noticed here is the rising government support and the rising initiatives taken by the healthcare organizations to develop molecular diagnostics labs in order to provide services can be said as the driving factor for the market.
Covid-19 had a positive impact on the molecular diagnostic market, the rising covid patients and the rise in the number of testing’s all around the globe increase the demand for the molecular diagnostics labs, as the RTPCR test was the most profound thing during the pandemic the most important thing which we analyzed was the rise in the initiative by the official health organizations and government which contributed to the growth of the molecular diagnostic market, if we particularly focus on the plans and regulations which were assist by the FDA which most probably included EUA, PREP Act and several other initiatives which contributed to the growth of the market the major reason was the approval of several tests issued by the FDA which made it possible for the molecular diagnostics labs to conduct tests also there are other factors which contributed to the growth of the molecular diagnostics market is the digitalization and rise in the development of infrastructure because of the involvement of the governments to be precise, the circumstances which was created because of the pandemic contributed to the growth of the market also many of the key players have assured that the rise in the digital platforms during the covid 19 gives made it possible to conduct clinical trails through various modes of channel.
Drivers
The rise in the demand for the molecular diagnostics.
The rising budget for the molecular diagnostics by government.
As we mentioned earlier there has been a rise in the diseases all around the globe which increase the demand for the molecular diagnostics, the government of the developed and the undeveloped regions are very particular about the investments for the healthcare infrastructure and improving the current state of the healthcare End User another factor which we observed was the rising R&D and the investments related to the same which is considered as the driving factor for the molecular diagnostic market also the rising number of the startups for this market is the key factor which will contribute to the growth of the molecular diagnostic market.
Restrain
The high cost associated with the clinical trials as the rising inflation rates can affect the plans related to the development of the molecular diagnostics.
Opportunity
The rising digitalization and the rise in the infrastructure related to the molecular diagnostics which offers more personalized healthcare offerings in terms of monitoring and prevention of diseases.
The key players and the emerging players of this particular market are very particular in terms of advancing the clinical trials by implementing the latest technology like AI in diagnostics, healthcare which will help the healthcare professionals to prevent the disease in the early stages according to our analysis there is ben rise in the obesity percentage in the developed countries and health experts states obesity may lead to cancer risk so in this case the molecular diagnostic market will attract a lot of opportunities during the forecasted period.
Challenge
Rules and regulations imposed by the government and the official healthcare organizations in terms of approving the test and several medical drugs.
The war can affect the market in many terms, if we consider the eastern European countries, they have been facing a lot of issues which has disrupted the supply chain management and also has affected the economic condition of the nation, according to our hypothesis the economic condition the nation may affect the growth of the companies which can also resulting delay of future plans and programs related to the healthcare which can affect the market negatively. This report will give you the exact details about how the Russia-Ukraine war has affected the market.
By Product & Service:
Reagents & Kits
Instruments
Services & Software’s
By Technology:
Polymerase Chain Reaction (PCR)
INAAT
Next-Generation Sequencing (NGS)
Other Technologies
By Application:
Infectious Disease Diagnostics
Oncology Testing
Genetic Testing
Other Applications
By End User:
Diagnostics Laboratories
Hospitals & Clinics
Others
Get Customized Report as per Your Business Requirement - Request For Customized Report
APAC will be the region with the highest growth rate because of the rising government initiative and the plans related to the development of the molecular diagnostics labs which will help the market to grow during the forecasted period also the rising infrastructure and the investments by the government and the private agencies to improve the healthcare sector in the developed and the emerging countries of the APAC will drive the market.
The major key players are as follows Grifols S.A, Hologic Inc, Abbott laboratories, F, Hoffmon LA-Roche LTD, Siemens Ag, Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc. and others.
Roche – The introduction of navify sample tracking, the major factor of this system is that it tracks the patient test samples before even reaching lab premises.
Becton Dickinson and Company – The company has invested €4 Million on its news R&D Centre which is located in Dublin.
The final report will give the exact details and the latest development related to the developments and the investments and how it is particularly shaping the molecular diagnostic market.
| Report Attributes | Details |
| Market Size in 2023 | US$ 24.27 Bn |
| Market Size by 2031 | US$ 36.94 Bn |
| CAGR | CAGR of 5.4 % From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product & Service (Reagents & Kits, Instruments, Services & Software’s) • By Technology (PCR, INAAT, NGS, Other Technologies) • By Application (Infectious Disease Diagnostics, Oncology Testing, Genetic Testing, Other Applications) • By End User (Diagnostics Laboratories, Hospitals & Clinics, Others) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Grifols S.A, Hologic Inc, Abbott laboratories, F, Hoffmon LA-Roche LTD, Siemens Ag, Danaher Corporation, Becton Dickinson and Company, Agilent Technologies Inc. and others. |
| Key Drivers | • The rise in the demand for the molecular diagnostics. • The rising budget for the molecular diagnostics by government. |
| Market Opportunities | • The rising digitalization and the rise in the infrastructure related to the molecular diagnostics which offers more personalized healthcare offerings in terms of monitoring and prevention of diseases. |
Ans ; Molecular Diagnostics Market size was valued at USD 23 billion in 2022 and is expected to reach at USD 34.50 billion by 2030, and grow at a CAGR of 5.2 % over the forecast period of 2023-2030.
Ans : The rise in the demand for the molecular diagnostics.
Ans : Rules and regulations imposed by the government and the official healthcare organizations in terms of approving the test and several medical drugs.
Ans : APAC will be the region with the highest growth rate
Ans : Covid-19 had a positive impact on the molecular diagnostic market
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID 19 Impact Analysis
4.2 Impact of the Ukraine- Russia war
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Molecular Diagnostics Market Segmentation by Product & Service
8.1 Reagents & Kits
8.2 Instruments
8.3 Services & Software’s
9. Molecular Diagnostics Market Segmentation by Technology
9.1PCR
9.2 INAAT
9.3 NGS
9.4 Other Technologies
10. Molecular Diagnostics Market Segmentation by Application
10.1 Infectious Disease Diagnostics
10.2 Oncology Testing
10.3 Genetic Testing
10.4 Other Applications
11. Molecular Diagnostics Market Segmentation by End User
11.1 Diagnostics Laboratories
11.2 Hospitals & Clinics
11.3 Others
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 North America Molecular Diagnostics Market by country
12.2.2North America Molecular Diagnostics Market by Product & Service
12.2.3 North America Molecular Diagnostics Market by Technology
12.2.4 North America Molecular Diagnostics Market by Application
12.2.5 North America Molecular Diagnostics Market by End User
12.2.6 USA
12.2.6.1 USA Molecular Diagnostics Market by Product & Service
12.2.6.2 USA Molecular Diagnostics Market by Technology
12.2.6.3 USA Molecular Diagnostics Market by Application
12.2.6.4 USA Molecular Diagnostics Market by End User
12.2.7 Canada
12.2.7.1 Canada Molecular Diagnostics Market by Product & Service
12.2.7.2 Canada Molecular Diagnostics Market by Technology
12.2.7.3 Canada Molecular Diagnostics Market by Application
12.2.7.4 Canada Molecular Diagnostics Market by End User
12.2.8 Mexico
12.2.8.1 Mexico Molecular Diagnostics Market by Product & Service
12.2.8.2 Mexico Molecular Diagnostics Market by Technology
12.2.8.3 Mexico Molecular Diagnostics Market by Application
12.2.8.4 Mexico Molecular Diagnostics Market by End User
12.3 Europe
12.3.1 Europe Molecular Diagnostics Market by country
1.3.3.2 Europe Molecular Diagnostics Market by Product & Service
12.3.3 Europe Molecular Diagnostics Market by Technology
12.3.4 Europe Molecular Diagnostics Market by Application
12.3.5 Europe Molecular Diagnostics Market by End User
12.3.6 Germany
12.3.6.1 Germany Molecular Diagnostics Market by Product & Service
12.3.6.2 Germany Molecular Diagnostics Market by Technology
12.3.6.3 Germany Molecular Diagnostics Market by Application
12.3.6.4 Germany Molecular Diagnostics Market by End User
12.3.7 UK
12.3.7.1 UK Molecular Diagnostics Market by Product & Service
12.3.7.2 UK Molecular Diagnostics Market by Technology
12.3.7.3 UK Molecular Diagnostics Market by Application
12.3.7.4 UK Molecular Diagnostics Market by End User
12.3.8 France
12.3.8.1 France Molecular Diagnostics Market by Product & Service
12.3.8.2 France Molecular Diagnostics Market by Technology
12.3.8.3 France Molecular Diagnostics Market by Application
12.3.8.4 France Molecular Diagnostics Market by End User
12.3.9 Italy
12.3.9.1 Italy Molecular Diagnostics Market by Product & Service
12.3.9.2 Italy Molecular Diagnostics Market by Technology
12.3.9.3 Italy Molecular Diagnostics Market by Application
12.3.9.4 Italy Molecular Diagnostics Market by End User
12.3.10 Spain
12.3.10.1 Spain Molecular Diagnostics Market by Product & Service
12.3.10.2 Spain Molecular Diagnostics Market by Technology
12.3.10.3 Spain Molecular Diagnostics Market by Application
12.3.10.4 Spain Molecular Diagnostics Market by End User
12.3.11 The Netherlands
12.3.11.1 Netherlands Molecular Diagnostics Market by Product & Service
12.3.11.2 Netherlands Molecular Diagnostics Market by Technology
12.3.11.3 Netherlands Molecular Diagnostics Market by Application
12.3.11.4 Netherlands Molecular Diagnostics Market by End User
12.3.12 Rest of Europe
12.3.12.1 Rest of Europe Molecular Diagnostics Market by Product & Service
12.3.12.2 Rest of Europe Molecular Diagnostics Market by Technology
12.3.12.3 Rest of Europe Molecular Diagnostics Market by Application
12.3.12.4 Rest of Europe Molecular Diagnostics Market by End User
12.4 Asia-Pacific
12.4.1 Asia Pacific Molecular Diagnostics Market by country
12.4.2 Asia Pacific Molecular Diagnostics Market by Product & Service
12.4.3 Asia Pacific Molecular Diagnostics Market by Technology
12.4.4 Asia Pacific Molecular Diagnostics Market by Application
12.4.5 Asia Pacific Molecular Diagnostics Market by End User
12.4.6 Japan
12.4.6.1 Japan Molecular Diagnostics Market by Product & Service
12.4.6.2 Japan Molecular Diagnostics Market by Technology
12.4.6.3 Japan Molecular Diagnostics Market by Application
12.4.6.4 Japan Molecular Diagnostics Market by End User
12.4.7 South Korea
12.4.7.1 South Korea Molecular Diagnostics Market by Product & Service
12.4.7.2 South Korea Molecular Diagnostics Market by Technology
12.4.7.3 South Korea Molecular Diagnostics Market by Application
12.4.7.4 South Korea Molecular Diagnostics Market by End User
12.4.8 China
12.4.8.1 China Molecular Diagnostics Market by Product & Service
12.4.8.2 China Molecular Diagnostics Market by Technology
12.4.8.3 China Molecular Diagnostics Market by Application
12.4.8.4 China Molecular Diagnostics Market by End User
12.4.9 India
12.4.9.1 India Molecular Diagnostics Market by Product & Service
12.4.9.2 India Molecular Diagnostics Market by Technology
12.4.9.3 India Molecular Diagnostics Market by Application
12.4.9.4 India Molecular Diagnostics Market by End User
12.4.10 Australia
12.4.10.1 Australia Molecular Diagnostics Market by Product & Service
12.4.10.2 Australia Molecular Diagnostics Market by Technology
12.4.10.3 Australia Molecular Diagnostics Market by Application
12.4.10.4 Australia Molecular Diagnostics Market by End User
12.4.11 Rest of Asia-Pacific
12.4.11.1 APAC Molecular Diagnostics Market by Product & Service
12.4.11.2 APAC Molecular Diagnostics Market by Technology
12.4.11.3 APAC Molecular Diagnostics Market by Application
12.4.11.4 APAC Molecular Diagnostics Market by End User
12.5 The Middle East & Africa
12.5.1 The Middle East & Africa Molecular Diagnostics Market by country
12.5.2 The Middle East & Africa Molecular Diagnostics Market by Product & Service
12.5.3 The Middle East & Africa Molecular Diagnostics Market by Technology
12.5.4 The Middle East & Africa Molecular Diagnostics Market by Application
12.5.5 The Middle East & Africa Molecular Diagnostics Market by End User
12.5.6 Israel
12.5.6.1 Israel Molecular Diagnostics Market by Product & Service
12.5.6.2 Israel Molecular Diagnostics Market by Technology
12.5.6.3 Israel Molecular Diagnostics Market by Application
12.5.6.4 Israel Molecular Diagnostics Market by End User
12.5.7 UAE
12.5.7.1 UAE Molecular Diagnostics Market by Product & Service
12.5.7.2 UAE Molecular Diagnostics Market by Technology
12.5.7.3 UAE Molecular Diagnostics Market by Application
12.5.7.4 UAE Molecular Diagnostics Market by End User
12.5.8 South Africa
12.5.8.1 South Africa Molecular Diagnostics Market by Product & Service
12.5.8.2 South Africa Molecular Diagnostics Market by Technology
12.5.8.3 South Africa Molecular Diagnostics Market by Application
12.5.8.4 South Africa Molecular Diagnostics Market by End User
12.5.9 Rest of Middle East & Africa
12.5.9.1 Rest of Middle East & Asia Molecular Diagnostics Market by Product & Service
12.5.9.2 Rest of Middle East & Asia Molecular Diagnostics Market by Technology
12.5.9.3 Rest of Middle East & Asia Molecular Diagnostics Market Application
12.5.9.4 Rest of Middle East & Asia Molecular Diagnostics Market by End User
12.6 Latin America
12.6.1 Latin America Molecular Diagnostics Market by country
12.6.2 Latin America Molecular Diagnostics Market by Product & Service
12.6.3 Latin America Molecular Diagnostics Market by Technology
12.6.4 Latin America Molecular Diagnostics Market by Application
12.6.5 Latin America Molecular Diagnostics Market by End User
12.6.6 Brazil
12.6.6.1 Brazil Molecular Diagnostics Market by Product & Service
12.6.6.2 Brazil Africa Molecular Diagnostics Market by Technology
12.6.6.3 Brazil Molecular Diagnostics Market by Application
12.6.6.4 Brazil Molecular Diagnostics Market by End User
12.6.7 Argentina
12.6.7.1 Argentina Molecular Diagnostics Market by Product & Service
12.6.7.2 Argentina Molecular Diagnostics Market by Technology
12.6.7.3 Argentina Molecular Diagnostics Market by Application
12.6.7.4 Argentina Molecular Diagnostics Market by End User
12.6.8 Rest of Latin America
12.6.8.1 Rest of Latin America Molecular Diagnostics Market by Product & Service
12.6.8.2 Rest of Latin America Molecular Diagnostics Market by Technology
12.6.8.3 Rest of Latin America Molecular Diagnostics Market by Application
12.6.8.4 Rest of Latin America Molecular Diagnostics Market by End User
13. Company Profile
13.1 Grifols S.A
13.1.1 Market Overview
13.1.2 Financials
13.1.3 Treatment/Services/Offerings
13.1.4 SWOT Analysis
13.1.5 The SNS View
13.2 Hologic Inc
13.2.1 Market Overview
13.2.2 Financials
13.2.3 Treatment/Services/Offerings
13.2.4 SWOT Analysis
13.2.5 The SNS View
13.3 Abbott laboratories
13.3.1 Market Overview
13.3.2 Financials
13.3.3 Treatment/Services/Offerings
13.3.4 SWOT Analysis
13.3.5 The SNS View
13.4 F, Hoffmon LA-Roche LTD
13.4.1 Market Overview
13.4.2 Financials
13.4.3 Treatment/Services/Offerings
13.4.4 SWOT Analysis
13.4.5 The SNS View
13.5 Siemens Ag
13.5.1 Market Overview
13.5.2 Financials
13.5.3 Treatment/Services/Offerings
13.5.4 SWOT Analysis
13.5.5 The SNS View
13.6 Danaher Corporation
13.6.1 Market Overview
13.6.2 Financials
13.6.3 Treatment/Services/Offerings
13.6.4 SWOT Analysis
13.6.5 The SNS View
13.7 Becton Dickinson and Company
13.7.1 Market Overview
13.7.2 Financials
13.7.3 Treatment/Services/Offerings
13.7.4 SWOT Analysis
13.7.5 The SNS View
13.8 Agilent Technologies Inc.
13.8.1 Market Overview
13.8.2 Financials
13.8.3 Treatment/Services/Offerings
13.8.4 SWOT Analysis
13.8.5 The SNS View
14. Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share analysis
14.3 Recent Developments
15. Use Cases and Best Practices
16. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Hyperphosphatemia Treatment Market size was valued at USD 2.58 Bn in 2022 and is expected to reach USD 3.84 Bn by 2030 with a CAGR of 5.1% over the forecast period of 2023-2030.
The Artificial Intelligence in Diagnostics Market was valued at USD 1172.46 Million in 2022 and is project to reach USD 5123.16 Million by 2030 with a growing CAGR of 23.45% during the forecast period 2023-2030.
The Prepacked Chromatography Columns Market Size was valued at USD 2.73 billion in 2022, and is expected to reach USD 5.49 billion by 2030 and grow at a CAGR of 9.1% over the forecast period 2023-2030.
The Healthcare Claims Management Market Size was valued at USD 13.52 billion in 2022, and is expected to reach USD 21.39 billion by 2030, and grow at a CAGR of 5.9% over the forecast period 2023-2030.
The Cancer biomarkers market size was estimated USD 13.21 billion in 2022 and is expected to reach USD 36.89 billion By 2030 at a CAGR of 13.7% during the forecast period of 2023-2030.
The Medical Swabs Market size was valued at USD 2.95 billion in 2022 and is expected to reach at USD 5.01 billion by 2030, and grow at a CAGR of 6.8% over the forecast period of 2023-2030
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
